SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as retail traders speculate on potential government contracts following a congressional disclosure of stock purchases, sparking comparisons to $PLTR. The community is actively discussing chart patterns and a potential short squeeze, with bullish investors highlighting the company's AI-driven solutions and anticipating a breakout. Chatter revolves around potential gains amidst growing interest in AI for defense and security.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following news of Elon Musk's $1 billion stock purchase, signaling confidence in the company's future and sparking a rally among investors. The community is debating whether this is a long-term bullish signal or a short-term pump, with some focusing on the company's potential in robotics and AI, while others point to ongoing concerns about valuation and market competition.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW.X is gaining attention as the 'crow with knife' meme coin community rallies around its multichain functionality across $SOL.X, $CRO.X, and $ETH.X. The project's fully circulated supply, organic community growth, and burn mechanism are key talking points, with many expressing bullish sentiment and calling it the 'only option'.

Slopana

$SLOPANA.X is gaining traction as the self-proclaimed 'king of digital slop,' capitalizing on the meme coin frenzy within the Solana ecosystem. Community members highlight its strong community, CTO leadership and are actively encouraging others to join before a potential surge, referencing its availability on Phantom Wallet.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community, the Wolfpack, rallies around the project, drawing comparisons to the early days of Shiba Inu and Saitama. Community members express strong conviction, anticipating significant gains and highlighting the project's solid floor and dedicated development team. Talk centers around a potential breakout and the revival of the 'Inu season' within the crypto space.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors assess the likelihood of upcoming Fed rate cuts and their potential impact on the market, especially tech. Community discussions revolve around the possibility of a "sell the news" event following the Fed's decision, with some traders expressing concerns about an overextended market. Meanwhile, broader market strength and individual stock movements like NVIDIA's $6.3B deal continue to fuel the conversation.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire ($RDW) is trending amid a newly announced partnership with Honeywell to develop quantum-secure satellite communication systems. The community is focused on the potential of this collaboration, particularly its implications for the company's future earnings and potential for a short squeeze given high short interest. Some investors are also weighing in on a recent settlement related to accounting irregularities, while others express optimism about the space sector and RDW's long-term prospects.

The New York Times Co. is a media organization, which engages in creating, collecting, and distributing news and information. It offers news products and other interest-specific products, and related content and services. It offers newspapers, print, and digital products and investments. The firm also manages The New York Times, NYTimes.com, and mobile applications. The company was founded by Henry Jarvis Raymond and George Jones on September 18, 1851, and is headquartered in New York, NY.

New York Times Co. - Ordinary Shares - Class A

New York Times ($NYT) is trending due to Trump's recent announcement of a $15 billion defamation lawsuit against the publication, sparking community debate about potential impacts. Earnings and AI deals have also captured attention, with community members weighing the potential for growth through digital subscriptions and partnerships with companies like Amazon. Some traders are discussing ratings and price targets from analysts, as well as potential market plays.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

CNSP is trending as traders discuss a recent orphan drug designation transfer and speculate on potential catalysts, while others express skepticism due to the company's history of reverse splits and clinical trial setbacks. Community members are actively debating the stock's potential for a short squeeze versus the risk of further dilution. Some traders are focusing on the low float and cash position, while others are warning against the stock's long-term prospects.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as its community rallies around its real-world brand-building efforts and growing holder base, highlighting a new energy drink flavor and upcoming meet-up. Community members express strong conviction in the project's long-term potential, emphasizing its unique approach and active development. Despite market fluctuations, the community remains focused on organic growth and strategic initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates

Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

U.S. stocks were on the backfoot on Wednesday as the all-important earnings from Nvidia Corp. (<a class="mention" data-mention="$NVDA" data-symbol-id="NVDA" href="https://stocktwits.com/symbol/NVDA" target="_blank">$NVDA</a>) looms large. Given hyped up expectations, the artificial intelligence stalwart has to issue not merely strong guidance but "insane" guidance that's not yet priced in, said LPLFinancial Chief Global Strategist Quincy Krosby.Ahead of the Nvidia's earnings due after the market close, the following stocks are eliciting most bearish sentiment from the retail crowd:Williams-Sonoma, Inc. (<a class="mention" data-mention="$WSM" data-symbol-id="WSM" href="https://stocktwits.com/symbol/WSM" target="_blank">$WSM</a>)Shares of San Francisco, California-based omni-channel specialty retailer of home products, soared to a record high following a beat-and-raise quarter.&nbsp;Retail largely ignored the positive results and the stock strength and fretted over valuation.&nbsp;<stembedurl>https://stocktwits.com/FetchDog/message/593355051</stembedurl>XP, Inc. (<a class="mention" data-mention="$XP" data-symbol-id="XP" href="https://stocktwits.com/symbol/XP" target="_blank">$XP</a>)&nbsp;XP shares fell over 5% after the Brazilian financial services company reported a double miss for the third quarter. Traders largely ignored a new share repurchase agreement announced by the company.Lineage Cell Therapeutics, Inc. (<a class="mention" data-mention="$LCTX" data-symbol-id="LCTX" href="https://stocktwits.com/symbol/LCTX" target="_blank">$LCTX</a>)Micro-cap clinical-stage biopharma Lineage Cell Therapeutics announced that it entered into definitive agreements with certain healthcare focused institutional investors and with Broadwood Partners, L.P. for raising up to $66 million in a registered direct offering of common stocks and warrants to purchase common stock. The stock was down over 30% at last check.Star Bulk Carriers Corp. (<a class="mention" data-mention="$SBLK" data-symbol-id="SBLK" href="https://stocktwits.com/symbol/SBLK" target="_blank">$SBLK</a>)Greek shipping company Star Bulk Carriers has seen its stock fall over 4.5% as traders digested its mixed earnings report released Tuesday after the close. Incidentally, peer ZIM Integrated Shipping Services Ltd. (<a class="mention" data-mention="$ZIM" data-symbol-id="ZIM" href="https://stocktwits.com/symbol/ZIM" target="_blank">$ZIM</a>) reported a double beat.&nbsp;e.l.f. Beauty, Inc. (<a class="mention" data-mention="$ELF" data-symbol-id="ELF" href="https://stocktwits.com/symbol/ELF" target="_blank">$ELF</a>)Shares of Oakland, California-based e.l.f. Beauty, a maker of cosmetics and skincare products, shed over 9% after short-seller Carson Block's Muddy Waters Research said it is short on the stock.&nbsp;"We believe it's overstating revenue, profits, inventory," the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/muddywatersre/status/1859273379145978200">said</a> in a post on X, adding that about 80% of its products are imported. Import data showed that the company's imports crashes by two-thirds, three quarters ago and haven't recovered since then, it added.The firm sees revenue overstatement to the tune of $135 million-$190 million.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/these-5-stocks-elicited-most-bullish-reactions-from-retail-mid-day-wednesday-novemeber-20/cJ46o5JRXJ"> 5 Stocks Retail Investors Are Most Bullish On At Mid-Day&nbsp;</a>

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

5 Stocks Retail Investors Are Most Bearish On At Mid-Day

Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.

Equity

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Lineage Cell Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.03	--	--	N/A
Q2 '25	-$0.03	-$0.13	-387.49%	MISSED
Q1 '25	-$0.03	-$0.02	22.22%	BEAT
Q4 '24	-$0.03	-$0.02	33.33%	BEAT
Q3 '24	-$0.04	-$0.02	50.00%	BEAT

LCTX
Lineage Cell Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest LCTX News

LCTX Lineage Cell Therapeutics Inc